AVANIR Pharmaceuticals Lands Research Deal with Novartis
By Business Review Editor
Pharma Deals Review: Vol 2005 Issue 60 (Table of Contents)
Published: 5 Jun-2005
DOI: 10.3833/pdr.v2005.i60.665 ISSN: 1756-7874
Section: Research & Development
Fulltext:
Abstract
AVANIR pharmaceuticals entered into a lucrative global research, development and commercialization agreement with Novartis to develop orally active small molecule therapeutics targeting macrophage migration inhibitory factor (MIF) for treating inflammatory diseases...
This page is available to subscribers only.
Not a subscriber? Join here
Already Registered? Please login using the top left purple box.
Copyright: © IQVIA 2018
RSS